- Tytuł:
- Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
- Autorzy:
- Źródło:
- Cancers [Cancers (Basel)] 2024 Mar 05; Vol. 16 (5). Date of Electronic Publication: 2024 Mar 05.
- Typ publikacji:
- Journal Article
Czasopismo naukowe